Cargando…

Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases

Psychiatric disorders such as schizophrenia and major depressive disorder were thought to be caused by neurotransmitter abnormalities. Patients with these disorders often experience relapse and remission; however the underlying molecular mechanisms of relapse and remission still remain unclear. Rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Yutaka, Chiba, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276905/
https://www.ncbi.nlm.nih.gov/pubmed/25429645
http://dx.doi.org/10.3390/ph7121028
_version_ 1782350312596570112
author Nakagawa, Yutaka
Chiba, Kenji
author_facet Nakagawa, Yutaka
Chiba, Kenji
author_sort Nakagawa, Yutaka
collection PubMed
description Psychiatric disorders such as schizophrenia and major depressive disorder were thought to be caused by neurotransmitter abnormalities. Patients with these disorders often experience relapse and remission; however the underlying molecular mechanisms of relapse and remission still remain unclear. Recent advanced immunological analyses have revealed that M1/M2 polarization of macrophages plays an important role in controlling the balance between promotion and suppression in inflammation. Microglial cells share certain characteristics with macrophages and contribute to immune-surveillance in the central nervous system (CNS). In this review, we summarize immunoregulatory functions of microglia and discuss a possible role of microglial M1/M2 polarization in relapse and remission of psychiatric disorders and diseases. M1 polarized microglia can produce pro-inflammatory cytokines, reactive oxygen species, and nitric oxide, suggesting that these molecules contribute to dysfunction of neural network in the CNS. Alternatively, M2 polarized microglia express cytokines and receptors that are implicated in inhibiting inflammation and restoring homeostasis. Based on these aspects, we propose a possibility that M1 and M2 microglia are related to relapse and remission, respectively in psychiatric disorders and diseases. Consequently, a target molecule skewing M2 polarization of microglia may provide beneficial therapies for these disorders and diseases in the CNS.
format Online
Article
Text
id pubmed-4276905
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-42769052015-01-15 Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases Nakagawa, Yutaka Chiba, Kenji Pharmaceuticals (Basel) Review Psychiatric disorders such as schizophrenia and major depressive disorder were thought to be caused by neurotransmitter abnormalities. Patients with these disorders often experience relapse and remission; however the underlying molecular mechanisms of relapse and remission still remain unclear. Recent advanced immunological analyses have revealed that M1/M2 polarization of macrophages plays an important role in controlling the balance between promotion and suppression in inflammation. Microglial cells share certain characteristics with macrophages and contribute to immune-surveillance in the central nervous system (CNS). In this review, we summarize immunoregulatory functions of microglia and discuss a possible role of microglial M1/M2 polarization in relapse and remission of psychiatric disorders and diseases. M1 polarized microglia can produce pro-inflammatory cytokines, reactive oxygen species, and nitric oxide, suggesting that these molecules contribute to dysfunction of neural network in the CNS. Alternatively, M2 polarized microglia express cytokines and receptors that are implicated in inhibiting inflammation and restoring homeostasis. Based on these aspects, we propose a possibility that M1 and M2 microglia are related to relapse and remission, respectively in psychiatric disorders and diseases. Consequently, a target molecule skewing M2 polarization of microglia may provide beneficial therapies for these disorders and diseases in the CNS. MDPI 2014-11-25 /pmc/articles/PMC4276905/ /pubmed/25429645 http://dx.doi.org/10.3390/ph7121028 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nakagawa, Yutaka
Chiba, Kenji
Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases
title Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases
title_full Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases
title_fullStr Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases
title_full_unstemmed Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases
title_short Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases
title_sort role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276905/
https://www.ncbi.nlm.nih.gov/pubmed/25429645
http://dx.doi.org/10.3390/ph7121028
work_keys_str_mv AT nakagawayutaka roleofmicroglialm1m2polarizationinrelapseandremissionofpsychiatricdisordersanddiseases
AT chibakenji roleofmicroglialm1m2polarizationinrelapseandremissionofpsychiatricdisordersanddiseases